Delayed kidney injury following coronary angiography

Wang,Feng; Peng,Cheng; Zhang,Guangyuan; Zhao,Qing; Xuan,Changyou; Wei,Meng; Wang,Niansong

doi:10.3892/etm.2016.3315

Delayed kidney injury following coronary angiography

Authors:
- Feng Wang
- Cheng Peng
- Guangyuan Zhang
- Qing Zhao
- Changyou Xuan
- Meng Wei
- Niansong Wang
View Affiliations

Affiliations: Department of Nephrology and Rheumatology, Affiliated Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai 200233, P.R. China, Department of Cardiothoracic Surgery, Affiliated Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai 200233, P.R. China, Department of Urology, Shanghai First Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, P.R. China, Department of Cardiology, Affiliated Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai 200233, P.R. China
Published online on: May 9, 2016 https://doi.org/10.3892/etm.2016.3315
Pages: 530-534

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

It is occasionally observed that patients without contrast-induced nephropathy (CIN) develop kidney injury within 1-6 months after coronary angiography (CAG), termed delayed CIN or delayed kidney injury (DKI) following CAG. The present study aimed to investigate the associated risk factors of delayed CIN and its possible pathogenesis. Subjects with CAG or coronary stenting from January 2008 to December 2009 were studied. A retrospective survey on DKI after CAG was conducted and the risk factors were analyzed. There were 436 cases receiving CAG with complete medical records enrolled in the present cohort, in which the DKI incidence was 7.1% (31/436). Patients with DKI after CAG exhibited lower hemoglobin (121.2±17.3 vs. 133.8±18.6 g/l), estimated glomerular filtration rate (eGFR; 66.4±30.2 vs. 71.9±28.6 ml/min), higher serum creatinine (110.9±43.2 vs. 91.7±37.6 µmol/l), higher rate of heart failure (22.6 vs. 5.4%) and 300 mg aspirin therapy (29 vs. 5.7%) compared with non‑DKI patients (all P<0.05). However, no differences were observed in morbidities of diabetes, hypertension, hyperlipidemia and proteinuria, or in the treatments with angiotensin converting enzyme (ACE) inhibitors/angiotensin II receptor‑1 blockers (ARBs), diuretics, statins and other anti-platelets between the two groups (P>0.05). Logistic regression revealed that anemia, heart failure and 300 mg aspirin intake were risk factors of DKI (P<0.05), while the contrast level, isotonic contrast, diabetes, ACE inhibitors/ARBs, eGFR and other factors were not associated with DKI (P>0.05). Heart dysfunction and 300 mg aspirin therapy may contribute to DKI after CAG, and iodinated contrast media administration is not a risk factor.

View Figures

View References

1	Koo HM, Doh FM, Ko KI, Kim CH, Lee MJ, Oh HJ, Han SH, Kim BS, Yoo TH, Kang SW and Choi KH: Diastolic dysfunction is associated with an increased risk of contrast-induced nephropathy: A retrospective cohort study. BMC Nephrol. 14:1462013. View Article : Google Scholar : PubMed/NCBI
2	James MT, Ghali WA, Tonelli M, Faris P, Knudtson ML, Pannu N, Klarenbach SW, Manns BJ and Hemmelgarn BR: Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function. Kidney Int. 78:803–809. 2010. View Article : Google Scholar : PubMed/NCBI
3	Kelly AM, Dwamena B, Cronin P, Bernstein SJ and Carlos RC: Meta-analysis: Effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med. 148:284–294. 2008. View Article : Google Scholar : PubMed/NCBI
4	McCullough PA: Contrast-induced acute kidney injury. J Am Coll Cardiol. 51:1419–1428. 2008. View Article : Google Scholar : PubMed/NCBI
5	World Medical Association: World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. J Postgrad Med. 48:206–208. 2002.PubMed/NCBI
6	Solomon R: Contrast-induced acute kidney injury (CIAKI). Radiol Clin North Am. 47:783–788. 2009. View Article : Google Scholar : PubMed/NCBI
7	Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, et al: A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 44:1393–1399. 2004. View Article : Google Scholar : PubMed/NCBI
8	Gault MH, Longerich LL, Harnett JD and Wesolowski C: Predicting glomerular function from adjusted serum creatinine. Nephron. 62:249–256. 1992. View Article : Google Scholar : PubMed/NCBI
9	Toprak O: Conflicting and new risk factors for contrast induced nephropathy. J Urol. 178:2277–2283. 2007. View Article : Google Scholar : PubMed/NCBI
10	Davidson C, Stacul F, McCullough PA, Tumlin J, Adam A, Lameire N and Becker CR: CIN Consensus Working Panel: Contrast medium use. Am J Cardiol. 98:42K–58K. 2006. View Article : Google Scholar : PubMed/NCBI
11	Reed M, Meier P, Tamhane UU, Welch KB, Moscucci M and Gurm HS: The relative renal safety of iodixanol compared with low-osmolar contrast media: A meta-analysis of randomized controlled trials. JACC Cardiovasc Interv. 2:645–654. 2009. View Article : Google Scholar : PubMed/NCBI
12	Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, Marsch S and Roskamm H: Prevention of contrast media-associated nephropathy: Randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. 162:329–336. 2002. View Article : Google Scholar : PubMed/NCBI
13	Hogan SE, L'Allier P, Chetcuti S, Grossman PM, Nallamothu BK, Duvernoy C, Bates E, Moscucci M and Gurm HS: Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: A meta-analysis. Am Heart J. 156:414–421. 2008. View Article : Google Scholar : PubMed/NCBI
14	Mehran R and Nikolsky E: Contrast-induced nephropathy: Definition, epidemiology and patients at risk. Kidney Int Suppl. S11–S15. 2006. View Article : Google Scholar : PubMed/NCBI
15	Morcos SK: Prevention of contrast media nephrotoxicity - the story so far. Clin Radiol. 59:381–389. 2004. View Article : Google Scholar : PubMed/NCBI
16	Tanaka A, Ishii H, Sakakibara M, Okumura S, Jinno Y, Okada K, Suzuki S, Inoue Y and Murohara T: Temporary adjunctive cilostazol vs. clopidogrel loading for ST-segment elevation acute myocardial infarction. Am J Cardiovasc Drugs. 14:131–136. 2014. View Article : Google Scholar : PubMed/NCBI
17	Kim SJ and Bang OY: Antiplatelet therapy for preventing stroke in patients with chronic kidney disease. Contrib Nephrol. 179:119–129. 2013. View Article : Google Scholar : PubMed/NCBI
18	Harirforoosh S, Asghar W and Jamali F: Adverse effects of nonsteroidal antiinflammatory drugs: An update of gastrointestinal, cardiovascular and renal complications. J Pharm Pharm Sci. 16:821–847. 2013.PubMed/NCBI
19	Harmon JP and Zimmerman DL and Zimmerman DL: Anticoagulant and antiplatelet therapy in patients with chronic kidney disease: Risks versus benefits review. Curr Opin Nephrol Hypertens. 22:624–628. 2013. View Article : Google Scholar : PubMed/NCBI
20	Braam B, Joles JA, Danishwar AH and Gaillard CA: Cardiorenal syndrome-current understanding and future perspectives. Nat Rev Nephrol. 10:48–55. 2014. View Article : Google Scholar : PubMed/NCBI
21	Shamseddin MK and Parfrey PS: Mechanisms of the cardiorenal syndromes. Nat Rev Nephrol. 5:641–649. 2009. View Article : Google Scholar : PubMed/NCBI
22	Anand IS: Cardiorenal syndrome: A cardiologist's perspective of pathophysiology. Clin J Am Soc Nephrol. 8:1800–1807. 2013. View Article : Google Scholar : PubMed/NCBI
23	Clementi A, Virzi GM, Goh CY, Cruz DN, Granata A, Vescovo G and Ronco C: Cardiorenal syndrome type 4: A review. Cardiorenal Med. 3:63–70. 2013. View Article : Google Scholar : PubMed/NCBI
24	Haller C and Hizoh I: The cytotoxicity of iodinated radiocontrast agents on renal cells in vitro. Invest Radiol. 39:149–154. 2004. View Article : Google Scholar : PubMed/NCBI
25	Heyman SN, Reichman J and Brezis M: Pathophysiology of radiocontrast nephropathy: A role for medullary hypoxia. Invest Radiol. 34:685–691. 1999. View Article : Google Scholar : PubMed/NCBI
26	Liss P, Nygren A, Erikson U and Ulfendahl HR: Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla. Kidney Int. 53:698–702. 1998. View Article : Google Scholar : PubMed/NCBI
27	Deek H, Newton P, Sheerin N, Noureddine S and Davidson PM: Contrast media induced nephropathy: A literature review of the available evidence and recommendations for practice. Aust Crit Care. 27:166–171. 2014. View Article : Google Scholar : PubMed/NCBI